I R Ferguson|L L Smith - JoVE Visualize

Showing results (211-220 of 226) with videos related to

Pageof 23

Sort By:

The Journal of Investigative Dermatology|February 8, 2008

Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasisRichard B Warren, Rhodri L L Smith, Emanuela Campalani, et al.

Drug Testing and Analysis|October 21, 2014

Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horsesH K Knych, R M Arthur, M M Mitchell, et al.

Digestive Diseases and Sciences|June 1, 1994

Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled studyJ R Mathias, M H Clench, V G Reeves-Darby, et al.

Veterinary Parasitology|January 5, 2002

Persistent efficacy of doramectin topical solution against induced infestations of Bovicola bovis and Solenopotes capillatusJ E Lloyd, R Kumar, M A Grubbs, et al.

Carcinogenesis|June 1, 1995

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationP Carthew, K J Rich, E A Martin, et al.

International Journal of Sports Medicine|June 28, 2006

Changes in mucosal and humoral atopic-related markers and immunoglobulins in elite cyclists participating in the Vuelta a EspañaA J McKune, L L Smith, S J Semple, et al.

British Medical Journal|February 7, 1976

Metronidazole in prevention and treatment of bacteroides infections after appendicectomyA T Willis, I R Ferguson, P H Jones, et al.

Journal of Animal Science|October 13, 2006

Assessment of vasoconstrictive potential of D-lysergic acid using an isolated bovine lateral saphenous vein bioassayJ L Klotz, L P Bush, D L Smith, et al.

Journal of Inherited Metabolic Disease|September 5, 1998

From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drugE A Lock, M K Ellis, P Gaskin, et al.

JAMA|February 10, 1993

The epidemiology of bacillary angiomatosis and bacillary peliosisJ W Tappero, J Mohle-Boetani, J E Koehler, et al.

Pageof 23

Showing results (211-220 of 226) with videos related to

Sort By:

Pageof 23

The Journal of Investigative Dermatology|February 8, 2008

Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasisRichard B Warren, Rhodri L L Smith, Emanuela Campalani, et al.

Drug Testing and Analysis|October 21, 2014

Pharmacokinetics and selected pharmacodynamics of cobalt following a single intravenous administration to horsesH K Knych, R M Arthur, M M Mitchell, et al.

Digestive Diseases and Sciences|June 1, 1994

Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled studyJ R Mathias, M H Clench, V G Reeves-Darby, et al.

Veterinary Parasitology|January 5, 2002

Persistent efficacy of doramectin topical solution against induced infestations of Bovicola bovis and Solenopotes capillatusJ E Lloyd, R Kumar, M A Grubbs, et al.

Carcinogenesis|June 1, 1995

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationP Carthew, K J Rich, E A Martin, et al.

International Journal of Sports Medicine|June 28, 2006

Changes in mucosal and humoral atopic-related markers and immunoglobulins in elite cyclists participating in the Vuelta a EspañaA J McKune, L L Smith, S J Semple, et al.

British Medical Journal|February 7, 1976

Metronidazole in prevention and treatment of bacteroides infections after appendicectomyA T Willis, I R Ferguson, P H Jones, et al.

Journal of Animal Science|October 13, 2006

Assessment of vasoconstrictive potential of D-lysergic acid using an isolated bovine lateral saphenous vein bioassayJ L Klotz, L P Bush, D L Smith, et al.

Journal of Inherited Metabolic Disease|September 5, 1998

From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drugE A Lock, M K Ellis, P Gaskin, et al.

JAMA|February 10, 1993

The epidemiology of bacillary angiomatosis and bacillary peliosisJ W Tappero, J Mohle-Boetani, J E Koehler, et al.

Pageof 23